GoKawiilAmateur Biochemist Claims Garage Synthesis of ChatGPT-Designed Schizophrenia Drug
Douglas Yao, a self-taught chemist working outside any pharmaceutical company, says he used ChatGPT to design a new compound called PAC-3310, targeting the same receptor as the approved antipsychotic Cobenfy. He claims to have built a chemistry lab in his garage, synthesized the compound himself, and is now testing it in cell lines and mice, part of a broader effort to generate thousands of AI-designed drug candidates.